A detailed history of Raymond James & Associates transactions in Good Rx Holdings, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 394,006 shares of GDRX stock, worth $2.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
394,006
Previous 126,055 212.57%
Holding current value
$2.41 Million
Previous $983,000 178.54%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$6.69 - $9.05 $1.79 Million - $2.42 Million
267,951 Added 212.57%
394,006 $2.74 Million
Q2 2024

Jul 19, 2024

BUY
$6.5 - $8.91 $140,692 - $192,856
21,645 Added 20.73%
126,055 $983,000
Q1 2024

Apr 22, 2024

BUY
$5.37 - $8.35 $407,099 - $633,013
75,810 Added 265.07%
104,410 $741,000
Q4 2023

Jan 16, 2024

BUY
$4.44 - $6.7 $126,984 - $191,620
28,600 New
28,600 $191,000
Q3 2022

Oct 25, 2022

SELL
$4.67 - $7.81 $10,516 - $17,588
-2,252 Reduced 15.7%
12,089 $56,000
Q2 2022

Aug 12, 2022

BUY
$5.84 - $20.02 $3,124 - $10,710
535 Added 3.88%
14,341 $85,000
Q1 2022

May 11, 2022

BUY
$13.62 - $32.45 $36,433 - $86,803
2,675 Added 24.03%
13,806 $267,000
Q4 2021

Feb 08, 2022

SELL
$32.11 - $47.16 $1.15 Million - $1.69 Million
-35,930 Reduced 76.35%
11,131 $364,000
Q3 2021

Nov 02, 2021

SELL
$29.63 - $46.98 $629,637 - $998,324
-21,250 Reduced 31.11%
47,061 $1.93 Million
Q2 2021

Aug 11, 2021

SELL
$28.27 - $41.18 $75,791 - $110,403
-2,681 Reduced 3.78%
68,311 $2.46 Million
Q1 2021

May 14, 2021

BUY
$35.03 - $56.99 $136,687 - $222,374
3,902 Added 5.82%
70,992 $2.77 Million
Q4 2020

Feb 12, 2021

BUY
$33.76 - $57.16 $2.26 Million - $3.83 Million
67,090 New
67,090 $2.71 Million

Others Institutions Holding GDRX

About GoodRx Holdings, Inc.


  • Ticker GDRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 84,394,800
  • Market Cap $516M
  • Description
  • GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated pri...
More about GDRX
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.